ID
20876
Description
The purpose of the trial is to determine if extended-release dipyridamole + aspirin [Aggrenox, Asasa ntin] is superior to clopidogrel [Plavix], and if telmisartan [Micardis, Gliosartan, Kinzal, Kinzalm ono, Predxal, Pritor, Samertan, Telmisartan] is superior to placebo, in the presence of background antihypertensive therapy, in prevention of a second stroke in patients who have recently suffered a stroke and therefore are at high risk of suffering another one. Penultimate Visit (Next to last Visit) Study Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1
Lien
https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1
Mots-clés
Versions (1)
- 23/03/2017 23/03/2017 -
Téléchargé le
23 mars 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Penultimate Trial Medication Tobacco Use PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062
Penultimate Trial Medication Tobacco Use PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062
Description
Discontinuation Of Trial Medication
Alias
- UMLS CUI-1
- C0013227
- UMLS CUI-2
- C0457454
Description
Discontinuation Of Trial Medication
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0457454
Description
If the patient permanently discontinued one or more of the trial medications since the previous visit, please record detailed information on the Permanent Termination of Trial Medication page 48. Even if the patient has stopped all trial medication he/she should be encouraged to return for all remaining visits.
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0457454
- UMLS CUI [1,2]
- C0205355
Description
Discontinuation Of Trial Medication
Alias
- UMLS CUI-1
- C0013227
- UMLS CUI-2
- C0457454
Description
Drug
Type de données
integer
Alias
- UMLS CUI [1]
- C0013227
Description
Date Stopped
Type de données
date
Alias
- UMLS CUI [1]
- C1531784
Description
Date Restarted
Type de données
date
Alias
- UMLS CUI [1]
- C3173309
Description
Trial Medication due to an Adverse Event
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C1531784
Description
if Yes
Type de données
text
Alias
- UMLS CUI [1]
- C0877248
Description
Tobacco Use Status
Alias
- UMLS CUI-1
- C0543414
- UMLS CUI-2
- C0449438
Description
Smoked Last Week
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0543414
- UMLS CUI [1,2]
- C2987125
Description
Number of cigarettes per day
Type de données
float
Alias
- UMLS CUI [1,1]
- C0543414
- UMLS CUI [1,2]
- C3694146
Similar models
Penultimate Trial Medication Tobacco Use PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062
C0013227 (UMLS CUI-2)
C0457432 (UMLS CUI [1,2])
C0457454 (UMLS CUI-2)
C0457454 (UMLS CUI [1,2])
C0205355 (UMLS CUI [1,2])
C0457454 (UMLS CUI-2)
C1531784 (UMLS CUI [1,2])
C2987125 (UMLS CUI [1,2])
C3694146 (UMLS CUI [1,2])